OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.






